Atlas Trials

A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY)

Clinical trial NCT03979313 · COMPLETED

Trial details

NCT number
NCT03979313
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Respiratory Syncytial Virus Infections
Start date
2019-07-23
Primary completion
2021-03-11
Enrollment
3012

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.